Viewing Study NCT00504192


Ignite Creation Date: 2025-12-24 @ 3:53 PM
Ignite Modification Date: 2026-01-28 @ 6:59 AM
Study NCT ID: NCT00504192
Status: COMPLETED
Last Update Posted: 2014-05-20
First Post: 2007-07-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
Sponsor: Soonchunhyang University Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Biliary Tract Adenocarcinoma View
None Gemcitabine View
None Oxaliplatin View
None Combination Chemotherapy View
None Efficacy View
Keywords: